AdvaMed Calls on Congress to Prevent Government Shutdown
Whitaker: “A shutdown would have a cascading effect on the patients our companies serve”
WASHINGTON, D.C. – Today, AdvaMed, the Medtech Association, released the following statement from President and CEO Scott Whitaker on the potential government shutdown and the impact it could have on patients:
“As March 1 approaches, it is critical that Congress understand how a government shutdown could affect so many patients across the country who rely on access to life-saving diagnostic tests and treatments. Failing to adequately fund FDA or CMS could have direct consequences to our health care system, especially if the shutdown lasts long enough to force these agencies to use their reserves.
“A shutdown would have a cascading effect on the patients our companies serve. Many medtech companies are already awaiting FDA and CMS decisions and could face even lengthier review times, which in turn could force small medtech innovators to close their doors before patients ever even have the opportunity to take advantage of their life-improving or lifesaving technologies.
“On behalf of the entire medtech industry AdvaMed represents, I urge Congress and the President to come together to pass a bipartisan funding package that averts a government shutdown.”
# # #